Karen W. Phinney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karen W. Phinney has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Lane C. Sander
National Institute of Standards and Technology, Biomolecular Measurement Division and Chemical Sciences Division, Gaithersburg, MD 20899
11 shared publications- Katherine E. Sharpless
National Institute of Standards and Technology
5 shared publications Stephen A. Wise
National Institute of Standards and Technology, Biomolecular Measurement Division and Chemical Sciences Division, Gaithersburg, MD 20899
5 shared publicationsJames H. Yen
National Institute of Standards and Technology, Material Measurement Laboratory, Biomolecular Measurement Division, 100 Bureau Drive, Gaithersburg, MD 20899, United States
4 shared publications- Lane C. Sander
National Institute of Standards and Technology, Gaithersburg, MD 20899, USA
4 shared publications Susan S.-C. Tai
National Institute of Standards and Technology, Biomolecular Measurement Division and Chemical Sciences Division, Gaithersburg, MD 20899
4 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-7
Advances in the measurement of vitamin D binding protein
Vitamin D binding protein (DBP) is a polymorphic protein known for its function in transporting vitamin D metabolites. DBP also plays several other important roles in the body’s response to tissue damage and inflammation. Measurement of DBP is fundamental to understanding its relationship to vitamin D status and to elucidating potential links between DBP concentration and various health outcomes. Early studies on DBP primarily used antibody-based techniques for quantification, and mass spectrometry-based methods have been reported during the past decade. This review will outline the different methodologies used in DBP studies and to assign values to reference materials, describe their advantages and limitations, and highlight some future trends. Graphical abstract
- 15 September 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-7
Open AccessAdvances in the measurement of vitamin D binding protein
Vitamin D binding protein (DBP) is a polymorphic protein known for its function in transporting vitamin D metabolites. DBP also plays several other important roles in the body’s response to tissue damage and inflammation. Measurement of DBP is fundamental to understanding its relationship to vitamin D status and to elucidating potential links between DBP concentration and various health outcomes. Early studies on DBP primarily used antibody-based techniques for quantification, and mass spectrometry-based methods have been reported during the past decade. This review will outline the different methodologies used in DBP studies and to assign values to reference materials, describe their advantages and limitations, and highlight some future trends. Graphical abstract
- Open Access
- 24 July 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-10
Evaluation of almond and hazelnut reference materials for standardizing allergenic protein detection and quantification
- 24 July 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- p. 1-10
Open AccessEvaluation of almond and hazelnut reference materials for standardizing allergenic protein detection and quantification
- 30 September 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (40) , 21761-21762
The ACS Division of Analytical Chemistry Awards Program: Honoring Our Recent Awardees
- 30 September 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (40) , 21761-21762
The ACS Division of Analytical Chemistry Awards Program: Honoring Our Recent Awardees
- 28 July 2025
- Published by National Institute of Standards and Technology (NIST)
Certification of Standard Reference Material 927g bovine serum albumin (7 % solution)(total protein standard)
Standard Reference Material (SRM) 927g is intended for use in the standardization of procedures employed in clinical analyses for total serum protein, for critical evaluation of daily working standards used in these procedures, and as a reference standard for assays of total protein by colorimetric methods. A unit of SRM 927g consists of 10 ampoules, each containing approximately 2.2 mL of solution.
- 28 July 2025
- Published by National Institute of Standards and Technology (NIST)
Certification of Standard Reference Material 927g bovine serum albumin (7 % solution)(total protein standard)
Standard Reference Material (SRM) 927g is intended for use in the standardization of procedures employed in clinical analyses for total serum protein, for critical evaluation of daily working standards used in these procedures, and as a reference standard for assays of total protein by colorimetric methods. A unit of SRM 927g consists of 10 ampoules, each containing approximately 2.2 mL of solution.
- Open Access
- 8 January 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (3) , 1214-1222
Quantification of mRNA in Lipid Nanoparticles Using Mass Spectrometry
Lipid nanoparticle-encapsulated mRNA (LNP-mRNA) holds great promise as a novel modality for treating a broad range of diseases. The ability to quantify mRNA accurately in therapeutic products helps to ensure consistency and safety. Here, we consider a central aspect of accuracy, measurement traceability, which establishes trueness in quantity. In this study, LNP-mRNA is measured in situ using a novel liquid chromatography-mass spectrometry (LC-MS) approach with traceable quantification. Previous works established that oligonucleotide quantification is possible through the accounting of an oligomer's fundamental nucleobases, with traceability established through common nucleobase calibrators. This sample preparation does not require mRNA extraction, detergents, or enzymes and can be achieved through direct acid hydrolysis of an LNP-mRNA product prior to an isotope dilution strategy. This results in an accurate quantitative analysis of mRNA, independent of time or place. Acid hydrolysis LC-MS is demonstrated to be amenable to measuring mRNA as both an active substance or a formulated mRNA drug product.
- 8 January 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (3) , 1214-1222
Open AccessQuantification of mRNA in Lipid Nanoparticles Using Mass Spectrometry
Lipid nanoparticle-encapsulated mRNA (LNP-mRNA) holds great promise as a novel modality for treating a broad range of diseases. The ability to quantify mRNA accurately in therapeutic products helps to ensure consistency and safety. Here, we consider a central aspect of accuracy, measurement traceability, which establishes trueness in quantity. In this study, LNP-mRNA is measured in situ using a novel liquid chromatography-mass spectrometry (LC-MS) approach with traceable quantification. Previous works established that oligonucleotide quantification is possible through the accounting of an oligomer's fundamental nucleobases, with traceability established through common nucleobase calibrators. This sample preparation does not require mRNA extraction, detergents, or enzymes and can be achieved through direct acid hydrolysis of an LNP-mRNA product prior to an isotope dilution strategy. This results in an accurate quantitative analysis of mRNA, independent of time or place. Acid hydrolysis LC-MS is demonstrated to be amenable to measuring mRNA as both an active substance or a formulated mRNA drug product.
- 1 March 2023
- Published by National Institute of Standards and Technology (NIST)
Humanized monoclonal antibody IgG1k, NISTmAb RM 8671 summary of 5 year stability verification (5YSV)
NISTmAb RM 8671 is an IgG1k monoclonal antibody that has been extensively characterized and released as the first of its kind biopharmaceutical reference material in 2016. This material was intended primarily for use in evaluating the performance of methods for determining physicochemical and biophysical attributes of monoclonal antibodies. It also provides a representative test molecule for development of novel technologies for therapeutic protein characterization. The lifecycle management of NISTmAb includes a long-term stability verification to evaluate the homogeneity and stability for the first 3 lots (14HB-D001, 14HB-D-002, and 14HB-D-003) of this material. Initial certification to assign property values and confirm identification used a wide variety of analytical methods including UVVis spectrophotometry, size exclusion chromatography, capillary electrophoresis, dynamic light scattering, flow imaging, and peptide mapping. Reported here is a summary of these analytical methods and results for the 5-year stability verification (5YSV) for RM 8671 demonstrating the material is homogeneous and stable.
- 1 March 2023
- Published by National Institute of Standards and Technology (NIST)
Humanized monoclonal antibody IgG1k, NISTmAb RM 8671 summary of 5 year stability verification (5YSV)
NISTmAb RM 8671 is an IgG1k monoclonal antibody that has been extensively characterized and released as the first of its kind biopharmaceutical reference material in 2016. This material was intended primarily for use in evaluating the performance of methods for determining physicochemical and biophysical attributes of monoclonal antibodies. It also provides a representative test molecule for development of novel technologies for therapeutic protein characterization. The lifecycle management of NISTmAb includes a long-term stability verification to evaluate the homogeneity and stability for the first 3 lots (14HB-D001, 14HB-D-002, and 14HB-D-003) of this material. Initial certification to assign property values and confirm identification used a wide variety of analytical methods including UVVis spectrophotometry, size exclusion chromatography, capillary electrophoresis, dynamic light scattering, flow imaging, and peptide mapping. Reported here is a summary of these analytical methods and results for the 5-year stability verification (5YSV) for RM 8671 demonstrating the material is homogeneous and stable.
- 23 January 2020
- Published by Stanford University Press in Clinical Mass Spectrometry
- Vol. 16, 11-17
Assessing a method and reference material for quantification of vitamin D binding protein during pregnancy
• Maternal VDBP concentrations may predict negative pregnancy outcomes. • A method using LC-IDMS was developed to quantify VDBP tryptic peptides in serum. • Reference values for VDBP were assigned to SRM® 1949 Frozen Human Prenatal Serum.
- 23 January 2020
- Published by Stanford University Press in Clinical Mass Spectrometry
- Vol. 16, 11-17
Assessing a method and reference material for quantification of vitamin D binding protein during pregnancy
• Maternal VDBP concentrations may predict negative pregnancy outcomes. • A method using LC-IDMS was developed to quantify VDBP tryptic peptides in serum. • Reference values for VDBP were assigned to SRM® 1949 Frozen Human Prenatal Serum.
- Open Access
- 1 November 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (22) , 14569-14576
Absolute Quantification of RNA or DNA Using Acid Hydrolysis and Mass Spectrometry
Accurate, traceable quantification of ribonucleotide or deoxyribonucleotide oligomers is achievable using acid hydrolysis and isotope dilution mass spectrometry (ID-MS). In this work, formic acid hydrolysis is demonstrated to generate stoichiometric release of nucleobases from intact oligonucleotides, which can be then measured by ID-MS, facilitating true and precise absolute quantification of RNA, short linearized DNA, or genomic DNA. Surrogate nucleobases are quantified with a liquid chromatography-tandem mass spectrometry (LC-MS/MS) workflow, using multiple reaction monitoring (MRM). Nucleobases were chromatographically resolved using a novel cation exchange separation, incorporating a pH gradient. Trueness of this quantitative assay is estimated from agreement among the surrogate nucleobases, and by comparison to concentrations provided for commercial materials, or Standard Reference Materials (SRMs) from the National Institute of Standards and Technology (NIST). Comparable concentration estimates using NanoDrop Spectrophotometry or established from droplet-digital PCR (ddPCR) techniques agree well to the results. Acid hydrolysis-ID-LC-MS/MS provides excellent quantitative selectivity and accuracy while enabling SI-traceability to mass unit. Additionally, this approach can be uniquely useful for quantifying modified nucleobases, or mixtures.
- 1 November 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (22) , 14569-14576
Open AccessAbsolute Quantification of RNA or DNA Using Acid Hydrolysis and Mass Spectrometry
Accurate, traceable quantification of ribonucleotide or deoxyribonucleotide oligomers is achievable using acid hydrolysis and isotope dilution mass spectrometry (ID-MS). In this work, formic acid hydrolysis is demonstrated to generate stoichiometric release of nucleobases from intact oligonucleotides, which can be then measured by ID-MS, facilitating true and precise absolute quantification of RNA, short linearized DNA, or genomic DNA. Surrogate nucleobases are quantified with a liquid chromatography-tandem mass spectrometry (LC-MS/MS) workflow, using multiple reaction monitoring (MRM). Nucleobases were chromatographically resolved using a novel cation exchange separation, incorporating a pH gradient. Trueness of this quantitative assay is estimated from agreement among the surrogate nucleobases, and by comparison to concentrations provided for commercial materials, or Standard Reference Materials (SRMs) from the National Institute of Standards and Technology (NIST). Comparable concentration estimates using NanoDrop Spectrophotometry or established from droplet-digital PCR (ddPCR) techniques agree well to the results. Acid hydrolysis-ID-LC-MS/MS provides excellent quantitative selectivity and accuracy while enabling SI-traceability to mass unit. Additionally, this approach can be uniquely useful for quantifying modified nucleobases, or mixtures.
- 16 October 2017
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 16 (11) , 4185-4195
Quantification of Total Vitamin-D-Binding Protein and the Glycosylated Isoforms by Liquid Chromatography–Isotope Dilution Mass Spectrometry
Vitamin-D-binding protein (VDBP), a transporter of 25-hydroxyvitamin D metabolites, has three common isoforms. The relationship of the isoforms and their glycosylation state with various diseases has been under recent examination. In this work, liquid chromatography coupled to isotope dilution mass spectrometry was evaluated for quantification of VDBP, the three common isoforms, and total glycosylation. Protocols using guanidine, urea, RapiGest, trifluoroethanol, or tris buffer were also evaluated for optimal tryptic digestion. Differences in peptide release were detected between purified and plasma VDBP; however, for both protein sources, ELPEHTVK, TSALSAK, and VLEPTLK concentrations were reproducible between most protocols tested. The isoform-specific peptides, LPDATPK, LPDATPTELAK, and LPEATPTELAK, were optimally released when TFE was added to plasma. The total VDBP concentration calculated from the three shared peptides resulted in 97.6% accuracy compared with the concentration from amino acid analysis. Glycosylation of VDBP was also calculated for purified protein and donor samples using the ratio of the isoform-specific peptide(s) to the total protein concentration. Glycosylation of purified VDBP was found to be 99.5–111.1% the value determined by semiquantitative analysis of the intact protein by LC–MS. This approach may be used to quantify other samples containing a mixture of isoforms and post-translational modifications.
- 16 October 2017
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 16 (11) , 4185-4195
Quantification of Total Vitamin-D-Binding Protein and the Glycosylated Isoforms by Liquid Chromatography–Isotope Dilution Mass Spectrometry
Vitamin-D-binding protein (VDBP), a transporter of 25-hydroxyvitamin D metabolites, has three common isoforms. The relationship of the isoforms and their glycosylation state with various diseases has been under recent examination. In this work, liquid chromatography coupled to isotope dilution mass spectrometry was evaluated for quantification of VDBP, the three common isoforms, and total glycosylation. Protocols using guanidine, urea, RapiGest, trifluoroethanol, or tris buffer were also evaluated for optimal tryptic digestion. Differences in peptide release were detected between purified and plasma VDBP; however, for both protein sources, ELPEHTVK, TSALSAK, and VLEPTLK concentrations were reproducible between most protocols tested. The isoform-specific peptides, LPDATPK, LPDATPTELAK, and LPEATPTELAK, were optimally released when TFE was added to plasma. The total VDBP concentration calculated from the three shared peptides resulted in 97.6% accuracy compared with the concentration from amino acid analysis. Glycosylation of VDBP was also calculated for purified protein and donor samples using the ratio of the isoform-specific peptide(s) to the total protein concentration. Glycosylation of purified VDBP was found to be 99.5–111.1% the value determined by semiquantitative analysis of the intact protein by LC–MS. This approach may be used to quantify other samples containing a mixture of isoforms and post-translational modifications.
- 1 September 2017
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 100 (5) , 1253-1259
Value Assignment of Vitamin D Metabolites in Vitamin D Standardization Program Serum Samples
Assay variability has been cited as an obstacle to establishing optimal vitamin D exposure. As part of the Vitamin D Standardization Program (VDSP) effort to standardize the measurement of total 25-hydroxyvitamin D [25(OH)D], the value assignment of total 25(OH)D in 50 single-donor serum samples was performed using two isotope-dilution LC with tandem MS methods. Both methods are recognized as reference measurement procedures (RMPs) by the Joint Committee for Traceability in Laboratory Medicine. These samples and their assigned values serve as the foundation for several aspects of the VDSP. To our knowledge, this is the first time that two RMPs have been used to assign 25(OH)D values to such a large number of serum samples.
- 1 September 2017
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 100 (5) , 1253-1259
Value Assignment of Vitamin D Metabolites in Vitamin D Standardization Program Serum Samples
Assay variability has been cited as an obstacle to establishing optimal vitamin D exposure. As part of the Vitamin D Standardization Program (VDSP) effort to standardize the measurement of total 25-hydroxyvitamin D [25(OH)D], the value assignment of total 25(OH)D in 50 single-donor serum samples was performed using two isotope-dilution LC with tandem MS methods. Both methods are recognized as reference measurement procedures (RMPs) by the Joint Committee for Traceability in Laboratory Medicine. These samples and their assigned values serve as the foundation for several aspects of the VDSP. To our knowledge, this is the first time that two RMPs have been used to assign 25(OH)D values to such a large number of serum samples.